InvestorsObserver
×
News Home

Where Does Ardelyx Inc (ARDX) Stock Fall in the Biotechnology Field After It Has Risen 10.69% This Week?

Tuesday, April 20, 2021 02:38 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Ardelyx Inc (ARDX) Stock Fall in the Biotechnology Field After It Has Risen 10.69% This Week?

The 82 rating InvestorsObserver gives to Ardelyx Inc (ARDX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 100 percent of stocks in the Biotechnology industry, ARDX’s 82 overall rating means the stock scores better than 82 percent of all stocks.

Overall Score - 82
ARDX has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on ARDX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 82 means the stock is more attractive than 82 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Ardelyx Inc Stock Today?

Ardelyx Inc (ARDX) stock is trading at $7.97 as of 2:24 PM on Tuesday, Apr 20, a loss of -$0.84, or -9.48% from the previous closing price of $8.81. The stock has traded between $7.34 and $8.91 so far today. Volume today is elevated. So far 3,945,945 shares have traded compared to average volume of 2,335,983 shares.

Click Here to get the full Stock Score Report on Ardelyx Inc (ARDX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App